Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 9/20 | 0.41 |
| ▸ | NPY1R | P25929 | 5/20 | 0.41 |
| ▸ | NPY2R | P49146 | 4/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.39 |
| ▸ | AAK1 | Q2M2I8 | 4/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 2/20 | 0.37 |
| ▸ | KCNB1 | Q14721 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12444369 | 0.91 | NPY4R (0.42) | NPY4RNPY1RNPY2RNPY5RAAK1 | |
| SCHEMBL10261740 | 0.91 | NPY4R (0.44) | NPY4RNPY1RNPY2RNPY5RAAK1 | |
| SCHEMBL10262675 | 0.91 | NPY4R (0.42) | NPY4RNPY1RNPY2RNPY5RAAK1 | |
| SCHEMBL15277771 | 0.91 | NPY4R (0.42) | NPY4RNPY1RNPY2RNPY5RAAK1 | |
| SCHEMBL15138938 | 0.91 | NPY4R (0.42) | NPY4RNPY1RNPY2RNPY5RAAK1 | |
| SCHEMBL16285905 | 0.91 | NPY4R (0.42) | NPY4RNPY1RNPY2RNPY5RAAK1 | |
| SCHEMBL13973792 | 0.90 | NPY4R (0.41) | NPY4RNPY1RNPY2RNPY5RAAK1 | |
| SCHEMBL15277754 | 0.90 | NPY4R (0.43) | NPY4RNPY1RNPY2RNPY5RAAK1 | |
| SCHEMBL19945118 | 0.90 | NPY4R (0.43) | NPY4RNPY1RNPY2RNPY5RAAK1 | |
| SCHEMBL13815093 | 0.89 | AAK1 (0.43) | NPY4RNPY1RAAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2709619-B1 | COMPOUNDS FOR USE IN TREATMENT OF MUCOSITIS | CELLCEUTIX CORP (US) | 2017-10-11 | — | — | EP | disclosed |